This is a non-core endpoint: only basic statistics are computed.
Toxic effect of other noxious substances eaten as food
ST19_TOXIC_EFFECT_OTHER_NOXIO_SUBST_EATEN_FOOD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
137 |
4. Check minimum number of eventsNone |
137 |
5. Include endpointsNone |
137 |
6. Filter based on genotype QC (FinnGen only) |
137 |
Control definitions (FinnGen only)
- Control exclude
- ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T5[1-9]|T6[0-5]
- Name in latin
- Effectus toxicus aliarum substantiarum nocivarum cibo sumptarum
Similar endpoints
↥List of similar endpoints to
Toxic effect of other noxious substances eaten as food
based on the number of shared cases.
Similar with more cases:
- Toxic effects of substances chiefly nonmedicinal as to source
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 137 | 73 | 64 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 43.29 | 42.38 | 44.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 124
- Matched controls
- 1238
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T62.0
ICD-10 Finland
Toxic effect: Ingested mushrooms
+∞
123.4
97
*
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
147.2
23.5
24
*
T62.2
ICD-10 Finland
Toxic effect: Other ingested (parts of) plant(s)
+∞
16.0
15
*
X28
ICD-10 Finland
Contact with other specified venomous plants
+∞
12.7
12
*
T62.9
ICD-10 Finland
Toxic effect: Noxious substance eaten as food, unspecified
+∞
8.4
8
*
X48
ICD-10 Finland
Accidental poisoning by and exposure to pesticides
+∞
6.3
6
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.7
6.2
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002032) Base excess in Venous blood by calculation
24
82
3.34
5.93
2.7
3.4
mmol/l
1.1
2.1
0.90
19
58
(3012544) pH of Venous blood
24
82
3.34
5.93
2.7
3.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
60
3.52
5.27
4.0
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
67
406
2.27
5.24
5.6
5.4
mmol/l
1.2
1.2
1.33
59
368
(3028707) Methadone [Presence] in Urine by Screen method
13
34
4.12
4.65
3.8
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
68
439
2.09
4.31
5.5
6.4
mmol/l
1.2
1.2
0.97
58
375
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
57
3.05
3.67
2.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
69
2.85
3.64
3.8
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
43
249
2.06
3.53
2.2
2.0
u/l
326.4
185.4
0.58
43
239
(3015736) pH of Urine
57
373
1.90
3.26
3.3
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
11
6.64
3.22
2.3
2.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
87
2.52
3.19
3.6
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
87
2.52
3.19
3.6
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
52
334
1.90
3.12
5.6
5.2
—
—
—
0
0
(3026782) Osmolality of Urine
33
181
2.08
3.09
2.6
2.7
mosm/kgh2o
477.5
561.1
1.25
27
151
(3000991) Gas panel - Venous blood
18
76
2.58
3.04
6.7
6.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
89
2.46
3.04
3.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
83
2.50
3.00
3.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
90
2.43
2.97
3.5
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
40
239
1.95
2.96
5.5
4.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
99
790
1.91
2.89
3.6
3.7
pmol/l
14.7
14.8
0.26
92
706
(3032080) INR in Blood by Coagulation assay
50
326
1.84
2.82
13.9
7.9
inr
1.3
1.2
0.27
18
106
(3018418) pH of Serum or Plasma
43
269
1.87
2.75
3.3
3.9
ph
7.4
7.4
0.03
11
47
(3000850) Epithelial cells [#/volume] in Urine
35
206
1.94
2.68
2.6
2.5
e6/l
2.7
5.3
2.12
28
181
(3021960) Folate [Moles/volume] in Serum or Plasma
37
223
1.90
2.64
1.5
1.4
nmol/l
17.3
21.5
1.15
31
194
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
16
4.55
2.51
2.1
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
34
3.09
2.47
2.4
3.6
mmol/l
23.8
23.9
—
10
34
(3037467) Urinalysis macro (dipstick) panel - Urine
88
698
1.73
2.40
4.8
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
29
166
1.95
2.39
1.7
1.7
pmol/l
429.8
481.9
0.47
24
143
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
8
6.43
2.39
16.4
22.4
nmol/l
1299.4
1606.5
—
5
8
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
8
6.43
2.39
13.6
15.1
nmol/l
834.2
976.1
—
5
8
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
324
1.74
2.35
4.0
3.4
ng/l
19.2
25.7
0.78
31
212
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
112
961
1.91
2.24
4.9
4.3
mu/l
1.7
1.9
1.11
107
870
(4198724)
5
9
5.72
2.23
1.0
2.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
48
331
1.69
2.15
3.2
3.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
8
25
3.33
2.13
3.1
3.4
mmol/l
1.0
1.5
—
8
25
(3018095) Leukocytes [#/volume] in Urine
50
350
1.67
2.11
3.8
3.5
e6/l
18.1
34.9
0.52
37
243
(3022948) Iron [Moles/volume] in Serum or Plasma
24
135
1.94
2.08
2.3
2.0
umol/l
11.4
13.8
1.10
24
124
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
38
2.76
2.06
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
143
0.33
2.02
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
44
301
1.68
2.02
3.5
2.9
e6/l
25.0
52.6
0.57
36
230
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
25
145
1.89
1.98
3.0
1.7
%
1.6
1.5
0.62
25
129
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
277
1.69
1.96
1.6
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
16
3.87
1.95
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
22
124
1.92
1.90
2.1
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
15
73
2.18
1.89
1.6
1.8
nmol/l
13.8
15.0
0.26
15
68
(3011397) Hemoglobin [Presence] in Urine by Test strip
33
215
1.70
1.79
3.5
3.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
36
2.60
1.77
1.4
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
36
2.60
1.77
1.1
2.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
24
3.02
1.74
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
24
3.02
1.74
1.0
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
17
90
2.01
1.74
8.1
6.5
mmol/l
0.6
1.5
0.64
11
74
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
49
356
1.59
1.74
1.9
1.8
pmol/l
99.7
93.3
0.37
27
183
(3009261) Glucose [Presence] in Urine by Test strip
64
495
1.55
1.73
4.2
3.3
estimate
0.0
0.0
—
9
90
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
12
55
2.30
1.73
2.5
2.9
mmol/l
0.9
1.0
—
7
41
(3021601) Nitrite [Presence] in Urine by Test strip
63
486
1.55
1.72
5.7
4.4
estimate
0.0
0.0
0.00
11
95
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
160
1.77
1.72
1.3
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
39
270
1.62
1.68
4.3
3.5
estimate
0.0
0.0
—
9
93
(3019309) Folate [Moles/volume] in Red Blood Cells
25
153
1.78
1.68
1.7
1.5
nmol/l
1090.1
1211.4
0.40
19
113
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
52
386
1.56
1.67
4.3
3.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
7
25
2.89
1.67
1.0
1.1
—
58.0
—
0
5
(36304419) Bacteria [Presence] in Urine
38
262
1.62
1.66
3.6
2.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
32
2.59
1.62
3.4
2.6
%
37.5
44.0
—
8
32
(3035350) Ketones [Presence] in Urine by Test strip
63
491
1.52
1.62
4.0
3.2
estimate
0.0
0.0
0.00
11
95
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
54
408
1.53
1.59
2.0
2.3
nmol/l
76.1
72.5
0.36
49
357
(3013115) Eosinophils [#/volume] in Blood
69
550
1.51
1.59
7.5
5.7
e9/l
0.2
0.2
0.43
61
483
(3004789) Transferrin [Mass/volume] in Serum or Plasma
22
132
1.79
1.58
2.3
1.9
g/l
2.4
2.4
0.02
22
117
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
214
1.65
1.57
1.4
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
38
267
1.59
1.53
3.5
2.8
e6/l
0.2
0.3
0.56
31
196
(3006504) Eosinophils/100 leukocytes in Blood
64
506
1.50
1.51
6.3
5.2
%
2.7
2.7
0.07
58
470
(3001604) Monocytes [#/volume] in Blood
67
535
1.49
1.51
6.2
5.3
e9/l
0.6
0.6
0.08
59
461
(3019060) Gas panel - Arterial blood
11
52
2.21
1.49
4.3
4.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
67
536
1.49
1.49
6.4
5.3
e9/l
0.0
0.0
0.76
59
461
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
38
2.46
1.49
10.3
7.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
65
519
1.48
1.45
6.3
4.9
%
57.4
57.0
0.14
59
485
(3019069) Monocytes/100 leukocytes in Blood
64
510
1.48
1.43
6.5
5.4
%
8.4
8.4
0.00
59
478
(3022313) Gas panel - Capillary blood
9
40
2.34
1.43
3.1
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
23
145
1.70
1.40
2.3
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
66
531
1.47
1.40
6.2
5.1
%
28.6
28.6
0.01
60
496
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
119
1084
1.74
1.38
17.3
12.0
mg/l
20.9
22.3
0.20
91
818
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
18
2.84
1.29
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
14
78
1.89
1.26
2.7
4.3
%
0.2
0.3
—
5
24
(3022096) Basophils/100 leukocytes in Blood
61
491
1.44
1.26
6.3
5.2
%
0.6
0.6
0.02
55
455
(3003327) Ova and parasites identified in Stool by Light microscopy
8
37
2.23
1.23
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
37
2.23
1.23
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
26
2.37
1.20
1.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
13
72
1.89
1.20
2.8
4.3
%
0.4
0.3
—
5
16
(40758558) Short blood count panel - Blood
38
282
1.48
1.18
7.4
6.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
33
0.00
1.18
0.0
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
67
554
1.41
1.17
6.6
5.2
e9/l
1.8
1.9
0.61
59
492
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
20
2.55
1.16
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
7
30
2.40
1.14
4.0
4.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
44
339
1.44
1.13
2.7
3.0
mmol/l
2.3
2.4
0.77
39
292
(3021589) Normoblasts [#/volume] in Blood
59
480
1.40
1.12
10.1
7.5
e9/l
0.0
0.0
0.46
50
378
(3017181) Myelocytes/100 leukocytes in Blood
14
83
1.76
1.06
2.7
4.2
%
1.0
1.0
—
5
27
(3012516) Albumin [Mass/volume] in Urine
29
211
1.47
0.99
3.6
3.2
mg/l
1870.3
67.4
0.46
18
140
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
109
996
1.46
0.99
4.8
3.8
mmol/l
5.7
5.8
0.17
100
919
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
94
1.67
0.95
1.2
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
86
759
1.36
0.93
4.6
3.6
mm/h
12.0
10.3
0.45
79
695
(3048689) Calprotectin [Mass/mass] in Stool
23
162
1.50
0.92
2.3
2.2
ug/g
43.8
132.3
1.50
18
126
(4034850)
6
30
2.04
0.88
8.2
7.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
17
113
1.58
0.87
1.1
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
226
1.42
0.86
4.0
4.0
mg/mmol
1.5
9.1
1.08
16
146
(3014007) Fractional oxyhemoglobin in Arterial blood
8
45
1.83
0.86
12.3
8.3
%
94.7
94.8
—
8
45
(3044889) 12 lead EKG panel
77
674
1.33
0.85
4.2
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
73
1.71
0.85
2.9
3.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
24
174
1.46
0.84
3.5
3.2
ng/l
13.6
209.9
1.79
17
123
(3037522) Nuclear Ab [Titer] in Serum
19
131
1.52
0.84
1.2
1.3
titre
2184.0
445.9
—
5
27
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
98
1.60
0.82
3.0
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
48
1.71
0.80
12.3
7.9
%
1.2
1.3
—
8
48
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
25
0.00
0.80
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
26
0.00
0.79
0.0
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
16
108
1.55
0.77
1.1
1.3
—
—
—
0
0
(3013512) EKG study
32
249
1.37
0.77
3.8
3.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
24
2.12
0.75
1.2
1.2
e6/l
51.6
378.1
—
5
19
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
24
2.12
0.75
1.2
1.0
e6/l
1.6
3.4
—
5
18
(40761536) Microorganisms panel - Urine sediment
13
84
1.61
0.75
4.8
3.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
38
1.89
0.75
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
38
1.89
0.75
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
26
1.96
0.71
1.2
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
43
1.66
0.68
1.0
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
16
112
1.49
0.67
12.6
19.0
—
1.4
—
0
18
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
111
1040
1.35
0.67
4.9
4.1
mmol/l
2.9
2.8
0.70
101
958
(3013650) Neutrophils [#/volume] in Blood by Automated count
72
640
1.26
0.65
11.3
8.7
e9/l
4.1
4.1
0.02
64
551
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
96
1.51
0.64
3.1
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
29
1.75
0.64
2.0
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
63
1.63
0.63
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
63
1.63
0.63
5.0
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
109
1021
1.33
0.63
4.4
3.7
mmol/l
4.8
4.7
0.80
100
943
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
80
1.55
0.62
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
51
1.60
0.61
1.6
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
106
1.47
0.60
1.4
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
81
1.53
0.59
1.1
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
35
1.75
0.58
2.2
2.6
%
0.7
0.7
—
6
35
(3045414) Leukocytes [Presence] in Urine
6
35
1.75
0.58
2.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
59
1.56
0.56
1.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
61
1.51
0.55
1.4
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
19
144
1.37
0.54
3.9
2.5
e6/l
5.3
2.6
0.39
12
78
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
66
1.56
0.54
1.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
105
987
1.27
0.53
15.9
11.0
ml/min/173m2
87.7
88.1
0.06
84
777
(3025159) Blasts/100 leukocytes in Blood
11
75
1.51
0.52
3.2
4.3
%
0.0
0.5
—
5
20
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
209
1.30
0.51
1.8
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
110
1042
1.28
0.50
19.7
11.8
%
39.0
40.9
1.62
83
831
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
96
896
1.24
0.50
6.0
4.8
mmol/mol
39.1
38.7
0.17
91
845
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
85
1.45
0.48
1.1
1.3
iu/ml
27.5
183.6
—
5
32
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
85
1.45
0.48
5.6
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
120
1151
1.34
0.48
15.4
10.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
48
1.48
0.47
13.9
7.9
%
0.8
0.7
—
7
48
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
107
1013
1.26
0.47
4.4
3.7
mmol/l
1.4
1.5
0.62
98
932
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
83
0.59
0.47
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
34
288
1.24
0.45
4.5
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
172
0.73
0.44
1.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
151
1.30
0.41
1.3
1.2
u/ml
32.3
6.8
—
7
56
(40768797) Stomach Pathology biopsy report
15
115
1.34
0.41
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
34
1.49
0.41
1.2
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
0.5
—
0
8
(3026008) Bacteria identified in Urine by Culture
34
292
1.22
0.40
4.3
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
35
1.44
0.39
2.8
2.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
9
66
1.39
0.39
2.6
2.9
g/l
68.7
67.0
—
9
60
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
36
1.40
0.38
1.6
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
227
1.24
0.38
1.9
2.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
98
928
1.20
0.38
21.9
13.9
%
13.6
13.5
0.37
98
913
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
42
1.45
0.36
1.0
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
45
1.35
0.34
4.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
119
1.29
0.33
3.6
6.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
158
1.24
0.30
1.4
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
151
0.77
0.30
2.4
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8
62
1.31
0.28
4.0
3.2
pmol/l
4.5
4.6
—
8
54
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
102
979
1.16
0.28
4.0
3.3
mmol/l
1.4
1.3
1.06
94
896
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
104
1.28
0.27
1.5
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
72
0.68
0.27
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
87
1.29
0.25
1.3
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
5
38
1.33
0.23
1.0
1.6
mg/l
4.8
3.2
—
5
26
(36660697) Celiac disease serology panel - Serum
7
95
0.72
0.23
1.6
1.1
—
—
—
0
0
(4035726)
7
95
0.72
0.23
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
40
1.26
0.22
1.0
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
154
1.19
0.22
4.1
2.3
e6/l
1.0
0.8
0.10
12
88
(40768804) Tissue Pathology biopsy report
42
386
1.13
0.22
2.0
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
13
108
1.23
0.21
1.9
2.7
%
1.5
1.7
0.55
13
97
(3000492) Spirometry study
9
111
0.80
0.21
1.1
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.4
—
96.5
—
0
14
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
17
148
1.17
0.18
2.5
2.8
ug/l
0.4
0.6
—
10
95
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
162
0.85
0.17
1.3
1.2
iu/ml
20.5
31.2
—
7
56
(1761868) Lipid panel - Serum or Plasma
34
366
0.91
0.15
2.4
2.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
87
842
1.09
0.15
3.6
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
28
303
0.90
0.14
2.1
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
47
1.07
0.09
1.6
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
13
117
1.12
0.08
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
28
264
1.08
0.08
1.4
1.4
g/l
1.7
2.4
1.56
15
153
(3019225) pH of Specimen
10
88
1.15
0.08
3.0
4.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
85
1.06
0.07
1.9
2.2
nmol/l
301.7
377.4
—
9
77
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
21
197
1.08
0.06
3.8
4.1
%
18.4
22.3
—
8
86
(3003694) ABO and Rh group [Type] in Blood
29
303
0.95
0.05
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
26
251
1.04
0.03
1.9
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
26
252
1.04
0.02
4.8
4.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
47
463
1.02
0.01
4.1
3.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
109
1.01
0.00
1.4
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
23
226
1.02
0.00
1.8
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
28
285
0.98
0.00
1.7
1.3
u/ml
0.5
1.0
—
5
64
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
3.0
—
12.4
—
0
6
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
0.1
—
0
7
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
11.9
—
0
6
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
110
1.00
0.00
1.3
1.6
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
75.3
—
0
5
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
12.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
145.2
—
0
5
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
13.5
—
0
7
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
149.2
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
104.0
—
0
6
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TOXIC_EFFECT_OTHER_NOXIO_SUBST_EATEN_FOOD – Toxic effect of other noxious substances eaten as food
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).